SWOG Articles

Articles

Intravesical Bacillus Calmette-Guérin Versus Combination of Epirubicin and Interferon-α2a in Reducing Recurrence of Non-Muscle-invasive Bladder Carcinoma: FinnBladder-6 Study.

Patients with non-muscle-invasive bladder cancer (NMIBC) belonging to the intermediate-risk group should be treated with intravesical instillations to prevent recurrence and progression.
We compared the outcome of a monthly maintenance bacillus Calmette-Guérin (BCG) regimen with that of epirubicin (EPI) and interferon-α2a (IFN) in patients with NMIBC.
Published May 11, 2016
Pathological T0 following radical cystectomy with or without neoadjuvant chemotherapy: A useful surrogate, "Beyond the Abstract," by Hugh J. Lavery, MD

BERKELEY, CA (UroToday.com) - Neoadjuvant chemotherapy has been recommended in multiple treatment guidelines for all patients with muscle-invasive bladder cancer (MIBC) undergoing cystectomy.
Published June 6, 2014